Profit: Research Therapy methods for the application of therapeutic vaccines HPV-AmpliVak in HPV+ head-neck tumors (Q3300939)

From EU Knowledge Graph
Revision as of 16:53, 24 October 2021 by DG Regio (talk | contribs) (‎Changed label, description and/or aliases in en: translated_label)
Jump to navigation Jump to search
Project Q3300939 in Germany
Language Label Description Also known as
English
Profit: Research Therapy methods for the application of therapeutic vaccines HPV-AmpliVak in HPV+ head-neck tumors
Project Q3300939 in Germany

    Statements

    country
    Germany
    0 references
    EU contribution
    3,743.8 Euro
    0 references
    budget
    467,975.01 Euro
    0 references
    co-financing rate
    0.8 percent
    0 references
    start time
    1 October 2020
    0 references
    end time
    30 September 2022
    0 references
    beneficiary name (string)
    AmpliVak Immunotherapy GmbH
    0 references
    location (string)
    Hennigsdorf, Stadt
    0 references

    Identifiers

    German Kohesio ID
    DE_TEMPORARY_3741
    0 references
     
    Retrieved from "https://linkedopendata.eu/w/index.php?title=Item:Q3300939&oldid=13379115"